Structures by: Beloborodova A. A.
Total: 7
4,4'-2Me-1,4-bis(5-phenylfuran-2-yl)benzene
C28H22O2
CrystEngComm (2017) 19, 13 1809
a=11.0733(7)Å b=6.1594(3)Å c=15.8500(12)Å
α=90.00° β=110.183(2)° γ=90.00°
1,4-bis(5-phenylfuran-2-yl)benzene
C26H18O2
CrystEngComm (2017) 19, 13 1809
a=20.407(4)Å b=7.2998(14)Å c=6.2000(11)Å
α=90.00° β=97.773(6)° γ=90.00°
3,5,3',5'-4Me-1,4-bis(5-phenylfuran-2-yl)benzene
C30H26O2
CrystEngComm (2017) 19, 13 1809
a=13.2404(6)Å b=5.4901(2)Å c=15.3541(7)Å
α=90.00° β=90.015(2)° γ=90.00°
Furosemide <i>N</i>,<i>N</i>-dimethylacetamide disolvate
C12H11ClN2O5S,2(C4H9NO)
Acta Crystallographica Section C (2016) 72, 12 997-1001
a=17.0284(10)Å b=7.8695(3)Å c=22.0555(15)Å
α=90° β=126.512(4)° γ=90°
Furosemide tetrahydrofuran solvate
C12H11Cl1N2O5S1,C4H8O1
Crystal Growth & Design (2014) 14, 2 513
a=10.9529(5)Å b=8.3816(3)Å c=20.0071(9)Å
α=90.00° β=95.024(4)° γ=90.00°
Furosemide N,N-dimethylformamide solvate
C12H11Cl1N2O5S1,C3H7N1O1
Crystal Growth & Design (2014) 14, 2 513
a=12.1430(5)Å b=12.4050(4)Å c=24.3562(11)Å
α=90.00° β=99.520(3)° γ=90.00°
Furosemide 1,4-dioxane solvate
C12H11Cl1N2O5S1,C4H8O2
Crystal Growth & Design (2014) 14, 2 513
a=7.9759(5)Å b=10.6923(7)Å c=10.9369(7)Å
α=86.247(5)° β=79.053(5)° γ=80.548(5)°